• First generic version of oncology medicine bortezomibe in Brazil
• New therapeutic option for patients suffering from multiple myeloma

São Paulo, August 26, 2014 – Sandoz, the generic pharmaceutical division of Novartis, today announces the market introduction in Brazil of the first generic version of oncology medicine bortezomibe.

Sandoz will distribute and promote bortezomibe in Brazil, based on an agreement with Accord Pharmaceuticals. This will be the first Sandoz medicine marketed in Brazil for treatment of hematologic – as opposed to …